Heart failure Laminopathy COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Centronuclear myopathy Errance diagnostique CRISPR AAV VECTOR Maladies rares et orphelines Maladies rares Myogenesis Allele-specific silencing therapy Next generation sequencing Myologie Heart A-type lamins Dystrophie musculaire C elegans Cardiac conduction system Emery-Dreifuss muscular dystrophy Dystrophine Rare diseases Angiotensin-converting enzyme inhibitors Laminopathie Butyrylcholinesterase Duchenne muscular dystrophy Patient registry Regeneration Cardiomyopathy C2C12 Mutations CMTX Adult SMA Emerin Laminopathies Congenital muscular dystrophy Angiotensin-converting enzyme inhibitor COVID-19 Becker muscular dystrophy Treatment Skeletal muscle Therapy Lamin A/C LMNA gene Diagnosis Muscle biopsy Muscle CSF protein Titin GNE RNA interference Dynamin 2 LMNA-related congenital muscular dystrophy A-type lamin Calcium handling Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS LMNA Lamins IPSC Joint laxity Dilated cardiomyopathy Biological sciences Treatment delay INPP5K Rare neuromuscular diseases Nuclear envelope Cardiology Muscular dystrophy Actionability Myopathy Lamin A/C nuclei LGMD Gene therapy Myopathies Biomarker Lamin A/C Muscular dystrophy MD Cancer biomarkers Connective tissue Allele-specific silencing Cancer BVES COL1A1 Neuromuscular diseases COL6A1 Ehlers‐Danlos Syndrome LMNA gene BiP Autophagosome maturation Hypermobile EDS Acetyltransferase Mouse Allele‐specific silencing therapy Exome Alternative splicing POPDC1 AAV Base de données FAIR Clinical trial Muscle MRI Actionable gene Myotubes